SC
RDY icon

Savant Capital’s Dr. Reddy's Laboratories RDY Stock Holding History

Savant Capital’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$432K Sell
29,832
-6,613
-18% -$89.2K ﹤0.01% 1296
2026
Q1 		$505K Buy
36,445
+8,313
+30% +$116K ﹤0.01% 906
2025
Q4 		$395K Sell
28,132
-1,730
-6% -$24.3K ﹤0.01% 930
2025
Q3 		$417K Buy
29,862
+4,480
+18% +$64.5K ﹤0.01% 870
2025
Q2 		$381K Buy
25,382
+15,001
+145% +$214K ﹤0.01% 852
2025
Q1 		$137K Sell
10,381
-3,569
-26% -$49.2K ﹤0.01% 1026
2024
Q4 		$220K Buy
+13,950
New +$210K ﹤0.01% 1279

Other funds holding RDY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
AIM
Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Savant Capital's RDY Position: Q2 2026 in Review

Savant Capital reduced its Dr. Reddy's Laboratories (RDY) stake by 18% in Q2 2026, selling an estimated $89.2K and leaving 29,832 shares worth $432K. The position accounts for ﹤0.01% of the portfolio, ranked #1296.

Savant Capital first reported a position in RDY in Q4 2024 and has held it in 7 quarters since. The position peaked at $505K in Q1 2026. 239 funds tracked by Wall St. Rank hold RDY as of Q2 2026.

  • Savant Capital held 29,832 shares of Dr. Reddy's Laboratories worth $432K as of Q2 2026.
  • Savant Capital sold 6,613 Dr. Reddy's Laboratories shares in Q2 2026, an estimated $89.2K.
  • Dr. Reddy's Laboratories made up ﹤0.01% of Savant Capital's portfolio in Q2 2026, its #1296 holding.
  • Savant Capital first reported a position in Dr. Reddy's Laboratories in Q4 2024 and has held it in 7 quarters since.
  • Savant Capital's Dr. Reddy's Laboratories position peaked at $505K in Q1 2026.
  • 239 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.

Based on Savant Capital's 13F filing for Q2 2026, filed 10 Aug 2026.